2023 annual financial data
Beam Therapeutics 2023 Net margin
Direct answer
Net margin was -35.09%.
Operating income was -176,485,000 USD and net income was -132,527,000 USD.
Operating cash flow was -149,195,000 USD.
Get free Beam Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 377,709,000 USD
- Operating income
- -176,485,000 USD
- Net income
- -132,527,000 USD
- Operating cash flow
- -149,195,000 USD